Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment.
Acúrcio RC, Pozzi S, Carreira B, Pojo M, Gómez-Cebrián N, Casimiro S, Fernandes A, Barateiro A, Farricha V, Brito J, Leandro AP, Salvador JAR, Graça L, Puchades-Carrasco L, Costa L, Satchi-Fainaro R, Guedes RC, Florindo HF.
Acúrcio RC, et al. Among authors: guedes rc.
J Immunother Cancer. 2022 Jul;10(7):e004695. doi: 10.1136/jitc-2022-004695.
J Immunother Cancer. 2022.
PMID: 35863821
Free PMC article.